Taysha Gene Therapies, Inc. (TSHA)

NASDAQ: TSHA · Real-Time Price · USD

2.450

+0.020 (0.82%)

At close: Jul 3, 2025, 1:00 PM

2.500

+0.050 (2.04%)

After-hours: Jul 3, 2025, 4:31 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Adeno-Associated Viruses-based Gene Therapies	15.45M	Log In
Adeno-Associated Viruses-based Gene Therapies Growth	517.55%	Log In

Revenue by Geography

Fiscal year is January - December.